Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Alchemab Therapeutics

Alchemab Therapeutics

Series A
London, UKFounded 2019Sep 2025
Healthtech

Alchemab Therapeutics closed a Series A round (amount undisclosed) in Sep 2025. The company is based in London, UK. Investors in the round: DCVC Bio, Lightstone Ventures, Lilly and 3 others. Data as of Nov 2026.

← Alchemab Therapeutics
Amount raised
—
undisclosed
Native amount
—
Stage
Series A
series a
Investors
6

Provenance & confidence

Unverified
Amount

Amount undisclosed or unconverted.

Unverified
Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

6 named
DCVC BioLightstone VenturesLillyOno Venture Investment (OVI)RA CapitalSV Health Investors
Date
Sep 2025
Round type
series a
Amount (EUR)
—

Other rounds

same company

Related news